Pharmacokinetics of phenylbutazone in healthy subjects after oral administration of single and multiple doses

The comparative effects of single and multiple doses of RS-8359, moclobemide and placebo on psychomotor function in healthy subjects

European Neuropsychopharmacology ◽

10.1016/0924-977x(96)83010-0 ◽

1996 ◽

Vol 6 ◽

pp. S4-65-S4-66

Author(s):

K. Puechler ◽

K. Schaffler ◽

C.-H. Wauschkuhn ◽

A. Plenker

Keyword(s):

Healthy Subjects ◽

Psychomotor Function ◽

Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once‐Weekly Dipeptidyl Peptidase‐4 (DPP‐4) Inhibitor, After Single and Multiple Doses in Healthy Subjects

The Journal of Clinical Pharmacology ◽

10.1002/jcph.773 ◽

2016 ◽

Vol 56 (12) ◽

pp. 1528-1537 ◽

Cited By ~ 16

Author(s):

Rajesh Krishna ◽

Carol Addy ◽

Daniel Tatosian ◽

Xiaoli S. Glasgow ◽

Isaias Noel Gendrano III ◽

...

Keyword(s):

Healthy Subjects ◽

Dipeptidyl Peptidase ◽

Pharmacokinetics And Pharmacodynamics ◽

Dipeptidyl Peptidase 4 ◽

Pharmacokinetics of meloxicam in rabbits after oral administration of single and multiple doses

American Journal of Veterinary Research ◽

10.2460/ajvr.74.4.636 ◽

2013 ◽

Vol 74 (4) ◽

pp. 636-641 ◽

Cited By ~ 26

Author(s):

Daniel V. Fredholm ◽

James W. Carpenter ◽

Butch KuKanich ◽

Micah Kohles

Keyword(s):

Oral Administration ◽

Pharmacokinetics of fluconazole after oral administration of single and multiple doses in African grey parrots

American Journal of Veterinary Research ◽

10.2460/ajvr.67.3.417 ◽

2006 ◽

Vol 67 (3) ◽

pp. 417-422 ◽

Cited By ~ 10

Author(s):

Keven Flammer ◽

Mark Papich

Keyword(s):

Oral Administration ◽

The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects

Clinical Drug Investigation ◽

10.1007/s40261-017-0513-4 ◽

2017 ◽

Vol 37 (7) ◽

pp. 659-667 ◽

Cited By ~ 28

Author(s):

Ka Lai Yee ◽

Sauzanne G. Khalilieh ◽

Rosa I. Sanchez ◽

Rachael Liu ◽

Matt S. Anderson ◽

...

Keyword(s):

Healthy Subjects ◽

Pharmacokinetics of single and multiple doses of flusoxolol (Ro 31-1411) in healthy subjects

European Journal of Clinical Pharmacology ◽

10.1007/bf00870998 ◽

1986 ◽

Vol 31 (1) ◽

pp. 113-115

Author(s):

H. C. Gillies ◽

H. J. Rogers ◽

R. J. Francis ◽

D. B. Galloway ◽

J. E. Humphreys

Keyword(s):

Healthy Subjects ◽

Pharmacokinetics and pharmacodynamics of single and multiple doses of the MAO-6 inhibitor lazabemide in healthy subjects

British Journal of Clinical Pharmacology ◽

10.1111/j.1365-2125.1997.tb00136.x ◽

1997 ◽

Vol 43 (1) ◽

pp. 41-47

Author(s):

Jasper Dingemanse ◽

Nolan Wood ◽

Karin Jorga ◽

Rolf Kettler

Keyword(s):

Healthy Subjects ◽

Pharmacokinetics And Pharmacodynamics ◽

Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study

European Journal of Drug Metabolism and Pharmacokinetics ◽

10.1007/s13318-015-0316-z ◽

2016 ◽

Vol 42 (1) ◽

pp. 37-48 ◽

Cited By ~ 2

Author(s):

Yani Liu ◽

Jianhong Wu ◽

Zhongfang Li ◽

Ying Luo ◽

Fandian Zeng ◽

...

Keyword(s):

Hepatic Fibrosis ◽

Healthy Subjects ◽

Human Study ◽

Open Label ◽

Multiple Doses ◽

Dose Escalating

A first in human study to investigate the safety, tolerability and pharmacokinetics of single and multiple doses of SMT19969 in male healthy subjects

http://isrctn.org/> ◽

10.1186/isrctn10858225 ◽

2014 ◽

Author(s):

Joseph Chiesa

Keyword(s):

Healthy Subjects ◽

Human Study ◽

Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects

Investigational New Drugs ◽

10.1023/b:drug.0000047104.45929.ea ◽

2005 ◽

Vol 23 (1) ◽

pp. 39-49 ◽

Cited By ~ 83

Author(s):

Aimee K. Bence ◽

Eric B. Anderson ◽

Maqbool A. Halepota ◽

Michael A. Doukas ◽

Phillip A. DeSimone ◽

...

Keyword(s):

Phase I ◽

Healthy Subjects ◽

Pharmacokinetic Studies ◽